Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2026-01-26 @ 10:07 PM
Study NCT ID:
NCT02736266
Status:
COMPLETED
Last Update Posted:
2023-07-18
First Post:
2016-04-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma
Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-23
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-09
First Submit QC Date:
None
Study First Post Date:
2016-04-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-14
Last Update Post Date:
2023-07-18
Last Update Post Date Type:
ACTUAL